Palladini G, et al. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood 2014; 124: 2325–2332. doi: 10.1182/blood-2014-04-570010

• PubMed
Palladini G, A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood 2014; 124: 2325–2332. doi: 10.1182/blood-2014-04-570010)| false
• Search Google Scholar
• Export Citation

Staron A, et al. Marked progress in AL amyloidosis survival: A 40-year longitudinal natural history study. Blood Cancer J 2021; 11: 1–10. doi: 10.1038/s41408-021-00529-w

• PubMed
Staron A, Marked progress in AL amyloidosis survival: A 40-year longitudinal natural history study. Blood Cancer J 2021; 11: 1–10. doi: 10.1038/s41408-021-00529-w)| false
• Search Google Scholar
• Export Citation

Sarosiek S, et al. Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis. Blood Cancer J 2020; 10:88. doi: 10.1038/s41408-020-00354-7

• PubMed
Sarosiek S, Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis. Blood Cancer J 2020; 10:88. doi: 10.1038/s41408-020-00354-7)| false
• Search Google Scholar
• Export Citation

Ng JH, et al. Outcomes of kidney transplantation in patients with myeloma and amyloidosis in the US. Nephrol Dial Transplant [published online ahead of print June 10, 2022]. doi: 10.1093/ndt/gfac196; https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfac196/6605285?login=false

• PubMed
Ng JH, Outcomes of kidney transplantation in patients with myeloma and amyloidosis in the US. Nephrol Dial Transplant [published online ahead of print June 10, 2022]. doi: 10.1093/ndt/gfac196; https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfac196/6605285?login=false)| false
• Search Google Scholar
• Export Citation

Angel-Korman A, et al. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int 2019; 95: 405–411. doi: 10.1016/j.kint.2018.09.021 [Erratum in Kidney Int 2019; 96:796. doi: 10.1016/j.kint.2019.06.001]

• PubMed
Angel-Korman A, Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int 2019; 95: 405–411. doi: 10.1016/j.kint.2018.09.021 [Erratum in Kidney Int 2019; 96:796. doi: 10.1016/j.kint.2019.06.001])| false
• Search Google Scholar
• Export Citation

Law S, et al. Renal transplant outcomes in amyloidosis. Nephrol Dial Transplant 2021; 36: 355–365. doi: 10.1093/ndt/gfaa293

• PubMed
Law S, Renal transplant outcomes in amyloidosis. Nephrol Dial Transplant 2021; 36: 355–365. doi: 10.1093/ndt/gfaa293)| false
• Search Google Scholar
• Export Citation

Heybeli C, et al. A study from the Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int 2021; 99: 707–715. doi: 10.1016/j.kint.2020.06.036

• PubMed
Heybeli C, A study from the Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int 2021; 99: 707–715. doi: 10.1016/j.kint.2020.06.036)| false
• Search Google Scholar
• Export Citation

Sawinski D, et al. Patient and kidney allograft survival in recipients with end-stage renal disease from amyloidosis. Transplantation 2018; 102: 300–309. doi: 10.1097/TP.0000000000001930

• PubMed
Sawinski D, Patient and kidney allograft survival in recipients with end-stage renal disease from amyloidosis. Transplantation 2018; 102: 300–309. doi: 10.1097/TP.0000000000001930)| false
• Search Google Scholar
• Export Citation